Panbela Therapeutics (PBLA)
OTHER OTC:PBLA
Holding PBLA?
Track your performance easily

Panbela Therapeutics (PBLA) Technical Analysis

239 Followers

Summary of all the Indicators

Overall Consensus
Sell
3Bullish
6Neutral
13Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Panbela Therapeutics’s (PBLA) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Panbela Therapeutics is a Buy.
Panbela Therapeutics’s (PBLA) 20-Day exponential moving average is 0.35, while Panbela Therapeutics’s (PBLA) share price is $0.33, making it a Sell.
Panbela Therapeutics’s (PBLA) 50-Day exponential moving average is 0.38, while Panbela Therapeutics’s (PBLA) share price is $0.33, making it a Sell.

Panbela Therapeutics (PBLA) Pivot Points

Sep 20, 2024, 07:47 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.31
0.32
0.33
0.34
0.35
0.36
0.38
Fibonacci
0.32
0.33
0.33
0.34
0.35
0.36
0.36
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Panbela Therapeutics (PBLA) Moving Averages

Sep 20, 2024, 07:47 AM
Period
Simple
Exponential
MA5
0.34Buy
0.34Sell
MA10
0.35Sell
0.34Sell
MA20
0.35Sell
0.35Sell
MA50
0.36Sell
0.38Sell
MA100
0.38Sell
1.07Sell
MA200
2.89Sell
4.48Sell
Panbela Therapeutics’s (PBLA) 10-Day exponential moving average is 0.34, while Panbela Therapeutics’s (PBLA) share price is $0.33, making it a Sell.
Panbela Therapeutics’s (PBLA) 100-Day exponential moving average is 1.07, while Panbela Therapeutics’s (PBLA) share price is $0.33, making it a Sell.
Panbela Therapeutics’s (PBLA) stock price is $0.33 and Panbela Therapeutics’s (PBLA) 50-day simple moving average is 0.36, creating a Sell signal.
Panbela Therapeutics’s (PBLA) stock price is $0.33 and Panbela Therapeutics’s (PBLA) 100-day simple moving average is 0.38, creating a Sell signal.
Panbela Therapeutics’s (PBLA) stock price is $0.33 and Panbela Therapeutics’s (PBLA) 200-day simple moving average is 2.89, creating a Sell signal.

Panbela Therapeutics (PBLA) Technical Indicators

Sep 20, 2024, 07:47 AM
Name
Value
Implied Action
RSI (14)
47.45
Neutral
STOCH (9,6)
33.85
Neutral
STOCHRSI (14)
23.81
Neutral
MACD (12,26)
>-0.01
Buy
ADX (14)
39.88
Neutral
Williams %R
-72.53
Buy
CCI (14)
-58.71
Neutral
ATR (14)
0.05
-
Ultimate Oscillator
52.84
Neutral
ROC
-5.56
Sell
Panbela Therapeutics’s (PBLA) Relative Strength Index (RSI) is 47.45, creating a Neutral signal.
Panbela Therapeutics’s (PBLA) Trend Strength Indicator (ADX) is 39.88, creating a Neutral signal.
Panbela Therapeutics’s (PBLA) Commodity Channel Index (CCI) is -58.71, creating a Neutral signal.
Panbela Therapeutics’s (PBLA) Price Rate of Change (ROC) is -5.56, creating a Sell signal.

FAQ

Is PBLA a Buy, Hold, or Sell?
Based on PBLA’s technical indicators, PBLA is a Sell.
    What is PBLA’s RSI (14)?
    PBLA’s RSI (14) is 47.45, which suggests PBLA is a Neutral.
      What is PBLA’s MACD?
      PBLA’s MACD is >-0.01, which suggests PBLA is a Buy.
        What is PBLA’s 5-day moving average?
        PBLA’s 5-day moving average is 0.34, which suggests PBLA is a Buy.
          What is PBLA’s 20-day moving average?
          PBLA 20-day moving average is 0.35, which suggests PBLA is a Sell.
            What is PBLA’s 50-day moving average?
            PBLA’s 50-day moving average is 0.36, which suggests PBLA is a Sell.
              What is PBLA’s 200-day moving average?
              PBLA’s 200-day moving average is 2.89, which suggests PBLA is a Sell.
                What is PBLA’s Williams % R (14)?
                PBLA’s Williams % R (14) is -72.53, which suggests PBLA is a Buy.
                  What is PBLA’s CCI (14)?
                  PBLA’s CCI (14) is -58.71, which suggests PBLA is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis